Text Zoom: - + + Print Page Email Page

Tarceva® erlotinib tablets
Tarceva + gemcitabine
Dosing & Administration

For Nurses

Indication and Usage

Tarceva in combination with gemcitabine is indicated for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.

The following resource is provided to inform and support nursing professionals in caring for patients with pancreatic cancer.


Genentech Biooncology (OSI) Oncology

Coverage and Reimbursement Support

Tarceva Access Solutions can help.
888-249-4918

Tarceva Co-Pay Card Program

Over 300 Enrollments as of 10/23/2009

Additional Resources


Tarceva® erlotinib tablets